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Abstract 
Many bacterial species readily develop biofilms that act as a protective matrix against 
external challenge, e.g. from antimicrobial treatment. Therefore, biofilms are often 
responsible for persistent and recurring infections. Established methods for studying biofilms 
are either destructive or they focus on the biofilm’s surface. A non-destructive method that is 
sensitive to the underside of the biofilm is highly desirable, as it allows studying the 
penetration of antibiotics through the film. Here, we demonstrate that the high surface 
sensitivity of resonant hyperspectral imaging provides this capability. The method allows us 
to monitor the early stages of Escherichia coli biofilm formation, cell attachment and 
microcolony formation, in-situ and in real time. We study the response of the biofilm to a 
number of different antibiotics and verify our observations using confocal microscopy. Based 
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on this ability to closely monitor the surface-bound cells, resonant hyperspectral imaging 
gives new insights into the antimicrobial resistance of biofilms. 
 
Introduction 
Biofilms are commonly defined as communities of surface-attached microorganisms 
embedded in an extracellular matrix that are attached to a surface. In most natural 
environments, polymicrobial biofilms are predominant and their survival often relies on 
intercellular communication and interactions (1,2). In the last few decades, biofilms have 
attracted great attention in areas ranging from environmental studies to industrial water 
systems, from the food industry to chronic infections (3-6). In fact, 60-80% of human 
bacterial infections, including many bloodstream and urinary tract infections, are caused by 
bacterial biofilms (7-10). Biofilm-based infections are extremely difficult to cure, as biofilms 
are intrinsically much less susceptible to antimicrobial agents than non-adherent, planktonic 
cells. There are two main mechanisms for antimicrobial tolerance in biofilms. The first is the 
failure of an antimicrobial agent to diffuse and penetrate into the depth of the biofilm. This is 
due to the extracellular polymeric matrix that forms the biofilm and that is known to retard 
the diffusion of antimicrobial agents (11), and solutes in general. Hence the substratum, i.e. 
the surface-bound underside of the biofilm, remains protected. The second mechanism is that 
some of the biofilm cells experience nutrient limitation and therefore exist in a slow-growing 
or starved state (8-14). Because of their much slower metabolism, slow growing or non-
growing cells are more tolerant of antimicrobial agents. 
 
Recent studies have also shown that microorganisms growing in a biofilm are highly resistant 
to antimicrobial agents (15-19). The antibiotic resistance in biofilms is generally caused by 
mutations and is driven by the repeated exposure of the bacteria to high levels of antibiotics 
as a consequence of treating the biofilm-associated infections, for instance (20,21). The 
minimum inhibitory concentration (MIC), defined as the lowest concentration of an 
antimicrobial that will inhibit the visible growth of a microorganism, is often considered as 
the ‘gold standard’ for determining the susceptibility of microorganisms to antimicrobials 
(22,23). As a result from both biofilm tolerance and antimicrobial resistance, it is known that 
a subset of the sessile bacteria in biofilms can survive in the presence of up to 1000 times 
MIC, compared to the planktonic cells (24,25). 
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To account for this discrepancy, new pharmacodynamic parameters, such as the minimum 
biofilm inhibitory concentration (MBIC) and the minimum biofilm eradication concentration 
(MBEC) have been introduced. To evaluate antimicrobial activity on sessile bacteria, in-vitro 
systems with abiotic surfaces have been developed over the last decade (24-27). Closed 
systems (batch culture), such as multi-well plate assays, the Calgary device, and open 
systems (continuous culture), such as substratum suspending reactors and the flow cell 
systems, are some of the most used in-vitro biofilm models for susceptibility studies (28), but 
they often require staining and/or dissolving the biofilms for visualisation and quantification, 
so they are typically destructive and do not allow monitoring the progression of antimicrobial 
activity. 
 
Despite all of the advances made in biofilm antimicrobial resistance and tolerance studies, a 
highly sensitive system that is able to monitor biofilm formation and dispersion in real time, 
non-destructively and quantitatively, is still missing. Monitoring the cell attachment and 
colonisation stage is paramount to this effort, as it allows for taking control of the early stages 
of biofilms and developing strategies for the prevention of mature biofilm formation. 
Similarly, monitoring the substratum of the biofilm is essential for understanding when 
antimicrobial action is completed. To address this challenge, we introduce the technique of 
resonant hyperspectral imaging to the monitoring of biofilms. We demonstrate the real time 
monitoring of cell attachment and the development of micro-colonies of Escherichia coli 
(E.coli) bacteria on the sensor surface with a range of initial inoculum density, starting from 2 
x 105 CFU/ml. Due to the high surface sensitivity of the guided-mode resonance we employ, 
we are able to focus on the underside of the biofilm where antibiotic access is most 
challenging. We are able to provide a clear picture of the early stage of biofilm formation and 
of the response of the biofilm to a range of antibiotics with varying doses. The unique 
information provided by resonant imaging may support the development of novel therapies 
for treating biofilm-associated infections.  
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Results 
Hyperspectral images of early-stage biofilms 
The key element of our biofilm sensor is a grating which supports a guided-mode resonance 
(GMR) (29). The grating is fabricated in a 150 nm thick silicon nitride (Si3N4) film on a glass 
substrate. Si3N4 has a high refractive index to support the guided mode, it exhibits minimal 
absorption at visible and near-infrared wavelengths, and most importantly, it is 
biocompatible, chemically inert and mechanically robust (30,31). We first simulate the 
grating design using rigorous coupled-wave analysis (RCWA) and fabricate structures with a 
period of 569 nm and a filling factor (defined as the fraction of high-refractive index material 
in one period) of 80% for a resonance wavelength operating at 850 nm. The evanescent tail of 
the guided mode extends beyond the grating layer and into the sensing region and thereby 
defines the detection volume. The size of the detection volume is determined by the 
difference between the effective index of the GMR and the refractive index of the sensing 
region, as is apparent from fundamental guided-mode theory (32); the detection volume is 
typically 100 -200 nm in depth and only extends into the first bacterial layer of the biofilm. 
Therefore, the sensor is able to monitor the very early stages of biofilm formation and the 
biofilm substratum, and is not susceptible to the background signal that arises from the bulk 
biofilm and the surrounding media. 
 
 
Fig 1. Experimental setup. A broadband light source (SM30, Leukos) combined with a 
grating-based monochromator is employed to generate a single illumination wavelength with 
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a spectral width of 0.6 nm, which is then guided into an inverted microscope with a 5x 
objective lens (Olympus NeoDplan). A GMR grating is mounted on the bottom of a flow cell 
with PDMS; the flow of E.coli culture is generated by a peristaltic pump with sterile silicone 
tubes from a reservoir of culture in a 37°C water bath. The flow cell is used to avoid 
detection of the planktonic cells that happened to land on the grating but are not involved in 
biofilm formation.  The camera used here is a CoolSnap Myo (Photometrics) with 970 x 730 
pixels. Images are captured using LabView, and image analysis and curve fitting are 
performed using MATLAB. 
 
Figure 1 is a schematic drawing of the experimental setup. The grating is placed into a flow 
cell to simulate the typical environment of interest, for instance a water pipe or the inside of 
the bladder, and to discourage settling of the bacteria. The flow is generated by a peristaltic 
pump with sterile silicone tubes. We used E. coli cultured in Luria-Bertani (LB) medium with 
an initial concentration of 2 x 108 CFU/ml and kept the bacteria in a 37 °C	water bath and 
flowed them through the sensor with a flow rate of 5 ml/s. Images from the sensor are formed 
hyperspectrally by taking a sequence of bright-field images that are typically obtained in less 
than 3 minutes depending on the camera’s integration time (usually set to be 1 s) and the 
wavelength resolution (usually set to be 0.2 nm), each at a different illumination wavelength 
achieved via a tunable monochromatic light source. For example, it takes just over 2 minutes 
for a scan of 25 nm wavelength range with 0.2 nm resolution, i.e. 125 images, and a 
hyperspectral image of the resonance is then generated within seconds. By analysing the 
intensity values of each bright-field image, the resonance wavelength for each pixel can be 
determined. By plotting the resonance wavelengths of all pixels in the array, we produce the 
hyperspectral images of the grating at resonance (for example in Fig. 2(a-d)). The resulting 
hyperspectral image contains the spectral response at every pixel within the microscope’s 
field of view. The region of interest (i.e. the center of the GMR grating) consists of 200 x 200 
pixels on the camera (corresponding to approximately 250 x 250 um2 in size). We then 
combine the resonance wavelengths of all 200 x 200 pixels in each hyperspectral image as a 
histogram (see Fig. 2(e-h)), and by fitting a Gaussian curve to this histogram, we obtain a 
central resonance wavelength (λn) for each hyperspectral image. It is worth nothing here that 
the distribution in the resonant wavelengths at time 0, defined as λ0, arises predominately 
from nanofabrication tolerances in a GMR grating. This uncertainty follows a normal 
distribution (33); hence, a Gaussian distribution is used to determine the central resonant 
wavelength and the resonance uniformity. Finally, the shift in the central resonance 
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wavelength (ᐃλ = λn – λi, while λi. is defined as the base value of the resonance wavelength, 
averaged over the first 30 min after the flow of culture is started) caused by the refractive 
index change given by the bacterial attachment and the formation of micro-colonies, is 
plotted over time (see Fig. 2(i)). It appears that the shift in resonant wavelength, ᐃλ, saturates 
after approximately 5 h, which indicates that the first layer of the biofilm has been 
established; while it is understood that the biofilm continues to grow, the technique is not 
sensitive to further increases in thickness. We also note here that in the plane of the grating 
surface, the spatial resolution is 2 μm along the grating grooves and 6 μm in the direction 
perpendicular to the grating grooves (34). 
 
 
Fig 2. Hyperspectral images and resonance wavelength shifts. (a-d) Hyperspectral images 
generated by the biofilm sensor at times 0 h, 2 h, 3.5 h and 6 h from the start of the 
experiment. The colour represents the resonance wavelength; (e-h) histogram data of 
resonance wavelengths of all pixels in (a-d) correspondingly, and Gaussian fit (red curve) to 
determine the central wavelength: λ0 (at 0 h), λb (at 2 h), λc (at 3.5 h) and λd (at 6 h); (i) plot of 
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the resonance wavelength shift, Δλ (Δλ  = λn  - λ0), against time (dots represent the central 
resonance wavelength λn from each Gaussian fit; shaded areas illustrate standard deviations 
of corresponding Gaussian fits and delineates the distribution of the resonance wavelengths 
of all 200 x 200 pixels) and the solid line is a sigmoidal fit to the data. Data showing long 
term (45 hours) stability of the biofilm sensor with fresh LB media introduced into the flow 
cell at 24 h. The initial E.coli concentration used here is 2 x 108 CFU/ml. 
 
Biofilm formation as a function of bacterial concentration 
Cultures of E.coli were diluted to different concentrations, ranging from 2 x 105 to 2 x 108 
CFU/ml. These dilutions were then used in separate experiments to inoculate the sensor and 
to study the rate of biofilm formation. We choose this range due to known clinical practice, 
where a specimen is considered positive for urinary tract infection in adults if the 
uropathogen concentration is greater than 105 CFU/ml (35). We then set the sensor to obtain a 
hyperspectral resonant image at intervals of 9 minutes. Figure 3(b-e) shows that resonance 
wavelength shift is characteristic of early stage single species biofilm formation, which 
appears with a similar shape of typical growth curves of planktonic cells (36), although the 
mechanisms behind the curves are rather different. The biofilm formation profiles detected 
within a 15-hour window can be described by three phases. Initially, planktonic bacteria 
attach to the surface - although some attachments are reversible (named “planktonic” phase). 
The attached cells then aggregate to form micro-colonies while excreting extracellular 
polymeric substances, making their attachment irreversible (named “colonies” phase). The 
bottom-layer of the biofilm is then considered established and continues to mature into a 
multi-layered cluster (“mature” phase). The “mature” phase, which can be upwards of 
multiple micrometres in thickness, is beyond the detection volume of our sensor and is 
therefore not “seen”, hence the resonance wavelength shift, ᐃλ, saturates. It is also known 
that the embedded biofilm cells do not divide and instead, their excess energy is used to 
maintain the extracellular matrix (11,37). This explains why the resonance wavelength, i.e. 
the refractive index on the sensor surface, remains constant after a certain period of time.  
 
A modified sigmoidal function is used to model the biofilm formation curves, see Fig. 3. As 
discussed above, the characteristic "S"-shaped biofilm formation curve appears similar to the 
typical shape of planktonic bacterial growth curve, where sigmoidal models, such as 
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Gompertz model, are commonly employed in analysis (36,38). Our modified sigmoidal 
function can be expressed in terms of the resonant wavelength shift, as follows:  𝛥𝜆 =	 11/𝐴	+	𝑒𝑥𝑝[−𝛼	∗	(𝑡	−	𝑡𝑝𝑙𝑎𝑛𝑘)]    Eq. 1 
where A is the amplitude of the profile, tplank is the time duration of the reversible cell 
attachment, which is indicated with a shaded region in Fig. 3, and 𝛼 is the biofilm formation 
rate. The relationship between the bacterial seeding density and the “planktonic” phase time 
tplank is discussed in SI. Although it is intuitive that a higher initial inoculum density leads to a 
shorter biofilm formation time, the technique readily allows us to quantify this formation 
time. More importantly, the technique allows us to quantify the biofilm’s response to 
antibiotics, as discussed in the next section. 
 
 
Fig. 3. Biofilm formation time as a function of E.coli concentration. (a) LB broth only, for 
reference. Concentrations of (b) 2 x 105, (c) 2 x 106, (d) 2 x 107, (e) 2 x 108 CFU/ml in LB. At 
least three independent replicates were performed for each concentration and reference. The 
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solid lines are sigmoidal fits to the data and the fitting parameters are presented in Table 1. 
The shaded region indicates the duration of the reversible cell attachment, tplank. 
 
Table 1. List of fitting parameters in Figure 3, with the R2 value for each fit. 
Initial concentration 
[cfu/ml] 
A 
[nm] 
tplank 
[h] 
𝜶 
[nm/h] 
R2 
2 x 105 0.952 8.22 0.428 0.92 
2 x 106  1.07 4.93 0.267 0.94 
2 x 107  1.09 3.40 0.260 0.96 
2 x 108  1.07 0.94 0.112 0.97 
 
 
Response of E.coli biofilms to antibiotics 
Next, we use the sensor to study the response of biofilms to antibiotic challenge, especially 
the response of the cells at the bottom layer of the biofilm. With monitoring the changes on 
the grating surface, we aim to detect which antibiotic can effectively disrupt the biofilm 
substratum. If the antibiotic causes a disruption to the distribution of the biofilm substratum, 
or partial or full detachment of the biofilm, we should observe a change in resonance 
wavelength of the grating. We use a concentration of 2 x 108 CFU/ml in order to speed up the 
process; using this concentration, the bottom layer of the biofilm is typically established 
within 5-6 hours (see Fig. S1). Our real-time, non-destructive monitoring capability then 
allows us to introduce antibiotics before, during and after a biofilm has been formed on the 
sensor surface. 
 
For uncomplicated lower urinary tract infections in adults, current UK NICE (The National 
Institute for Health and Care Excellence) guidelines recommend nitrofurantoin (which 
inhibits the citric acid cycle as well as synthesis of DNA, RNA, and protein, also a 
bactericidal antibiotic) and trimethoprim (a folic acid synthesis inhibitor, a bacteriostatic 
antibiotic) as first line antibiotics due to their low risk of microbial resistance (39). We 
therefore choose these two drugs as our model antibiotics. The MIC and the minimum 
bactericidal concentration (MBC) were pre-assayed with planktonic E.coli cells in 96-well 
plates (see SI for details). The MIC of trimethoprim for this strain is determined to be <1 
μg/ml and the MBC as 16-32 μg/ml. Trimethoprim with a dose of 1 μg/ml is therefore 
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introduced into the culture at times 0 h, 3.5 h and 5.0 h. We make the following observations 
(Fig. 4): 
• When the antibiotic is injected at time 0 h, it completely halts cell attachments, and no 
colonisation and subsequent multilayered biofilm formation is observed on the sensor 
surface;  
• When the antibiotic is added at 3.5 h, the colonies stop developing immediately upon 
introduction of the drug, halting any further establishment of the biofilm; 
• When 1x MIC of trimethoprim is added at 5.0 h (after the profile shows “saturation”), 
there is no observable change, i.e. the curve looks identical to the one without 
antibiotics added (see SI). This indicates that there is no change, i.e. in terms of 
colony density or detachment, at the bottom layer of the biofilm. 
 
Fig 4. Antimicrobial susceptibility testing in early-stage biofilms. A 1x MIC dose of 
trimethoprim is introduced to the culture at 0 h and at 3.5 h (as indicated by the vertical 
dashed lines). The solid black line is a sigmoidal fit to the data. After introducing the 
antibiotic, the data are fit to a straight line.  
 
In order to study the biofilm tolerance, we increase the dose of trimethoprim from 1 to 500x 
MIC (equivalent to 20x MBC approximately). The antibiotic solutions are administrated at 5 
h from the start of the experiments, i.e. after the monolayer of biofilm is established. There is 
no significant effect on the detected resonance wavelength at any dose (see Fig. 5(a) for 500x 
MIC and more details in SI). Because the sensor probes the substratum of the biofilm, i.e. the 
volume that is in direct contact with the grating, the results indicate that even with extremely 
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high doses of trimethoprim, the sensor does not detect significant changes. A separate study 
on nitrofurantoin reveals very similar results to trimethoprim (see SI for more information). 
We can therefore conclude that nitrofurantoin and trimethoprim are effective against 
planktonic cells, but not against biofilms formed by the same strain. 
 
Confocal fluorescence microscope images confirm our findings (Fig. 5 b, c, g, h). Following 
the addition of 500x MIC of trimethoprim, introduced to the culture at 5 h, the biofilm is 
allowed to continue “growing” for at least a further 5 h with the antibiotic present. We 
observe that there is still a good bacterial coverage on the grating after the multiple wash 
steps that are required during the staining process, and the majority of cells attached to the 
surface are still alive (Fig. 5c, and more confocal fluorescence images in SI). This confirms 
that the bottom layer of the biofilm is undisrupted, in agreement with our sensor result. As 
clearly observed in Fig 5 (c), there are too many surviving bacteria in the 500x MIC case that 
remain attached to the sensor surface to consider this a biofilm eradication concentration 
(MBEC). This observation indicates that the MBEC is higher than 500x MIC, i.e. 0.5 mg/ml 
in this case, which is also consistent with other reports employing fluorescent testing methods 
(24,25). Colony counting on agar plates after 24 h incubation revealed that there are living 
cells in the remaining biofilms. So our recognition that trimethoprim is not effective against 
biofilms is confirmed by multiple control methods.  
 
We then tested two other bactericidal antibiotics, i.e. rifampicin (an RNA synthesis inhibitor, 
can be bacteriostatic or bactericidal depending on concentrations) and ciprofloxacin (inhibits 
DNA replication and exhibits both bacteriostatic and bactericidal activities), and they have 
been suggested because of their efficacy against biofilms. Identifying the best antimicrobials 
against biofilms is an active area of research (13,40,41) that may benefit from a simple and 
real-time, non-destructive technique such as ours.  
 
With our biofilm sensor, the disruption at the bottom of biofilm is observed as a shift of the 
resonance wavelength shortly after the administration of ciprofloxacin to a biofilm after 5 h 
of growth (Fig. 5(f)). Confocal microscopy with the live/dead assay confirms that the 
coverage of bacteria on the sensor surface is significantly reduced, and the cells in one 
remaining colony attached to the surface are also mostly dead (red colour) or injured with 
compromised cell membranes (yellow colour), shown in Fig. 5(h). This outcome is 
significantly different to what we observe with the other antibiotics, even though the phase 
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contrast images of all these samples are rather similar (Fig. 5 d-e and i-j). The phase contrast 
images include not only the cells attached to the surface, but also the biofilms cells that are 
detached from the surface but near the surface as well as some planktonic cells. In contrast, 
confocal microscopy with the Live/Dead staining involves a few washing steps during the 
process (see Methods), therefore, the confocal images represent the biofilm cells that are still 
firmly attached to the sensor surface. In Fig. 5f, it certainly appears that 300x MIC 
ciprofloxacin results in a rapid and significant disruption on the bottom of the biofilm. 
Indeed, this disruption seems to cease after 5 hours and our hypothesis is that ciprofloxacin 
causes removal of majority of the biofilm on the sensor surface, leaving a small number of 
cells possibly with some exocellular matrix remaining on the surface, which is reflected by a 
small resonance wavelength shift after 10 h in Fig. 5(f). In short, our GMR sensor, compared 
to the conventional microscopic techniques, provides a non-destructive, rapid, dynamic 
sensing and analysis technique, which can provide real-time information of the very bottom 
of biofilm.  
 
 
Fig. 5. Three different techniques to monitor biofilms: GMR sensor (left), confocal 
fluorescence microscope (middle), and phase contrast microscope (right). Trimethoprim 
(final dose of 500x MIC, a-e) and ciprofloxacin (final dose of 300x MIC, f-j) injected at 5 h 
(dashed line) from the beginning of the experiment and microscopic images are obtained after 
10 h (dash dotted line) from the start of the experiments. Confocal microscopic images (b, c 
and g, h) and phase contrast images (d, e and i, j) are all taken at 10 h from the start of the 
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experiments; (c) and (h), (e) and (j) are confocal and phase contrast images of biofilms with 
antibiotic injected at 5 h from the start of the experiments, respectively; The scale bars in the 
micrographs are all 10 μm long. 
 
For ease of comparison and reproducibility, all of these studies have been performed in LB 
broth and each set of experiments has been repeated for a minimum of three times. We have 
also performed total biofilm removal experiments with 70% ethanol wash followed by a 
piranha etch (a 3:1 mixture of sulfuric acid and 30% hydrogen peroxide). This protocol 
removes any organic residues on the grating surface including the extracellular matrix. A 
total recovery of the original resonance wavelength is observed, which indicates that 
complete removal of biofilms can be detected by our sensor. To ensure clinical relevance, we 
have also demonstrated that the technique is compatible with undiluted human urine (see SI).   
Discussion 
In summary, we have introduced the technique of resonant hyperspectral imaging to 
monitoring the formation of Escherichia coli biofilms and have studied the response of these 
biofilms to a range of antibiotics. The key aspect that makes the technique so suitable for 
studying biofilms is that it only images the first few 100 nm from the bottom, i.e. the 
substratum, of the biofilm, which is the most important section of the film in terms of both 
early formation and antibiotic challenge. Because the technique is only sensitive to the 
substratum, the sensing signal is not affected by the media, the thickness of the biofilm or to 
any planktonic cells suspended in the media, so it is easy to achieve a high signal to noise 
ratio. Furthermore, within the same assay, a quantitative indication of the bacteria 
concentration can be readily obtained by monitoring the time it takes for the onset of biofilm 
formation. Given this real-time monitoring capability, the technique also allows antimicrobial 
resistance testing in-situ, therefore offering the opportunity of quantitatively analysing the 
action and progression of different antibiotics against the biofilm within minutes to a few 
hours. The non-destructive nature of the technique is a unique advantage, compared to, e.g., 
fluorescence-based microscopy techniques.  
 
We envisage that our system can be miniaturised into a hand-held device that could be 
implemented as a diagnostic within a clinical environment; such a realization would allow 
for, e.g. the tailoring of antibiotic therapies to individual patients. Alternatively, the technique 
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could be used for in-field biofilm detection, such as within water treatment plants or domestic 
water delivery pipes, food processing plants and equipment, heating, ventilation, and air-
conditioning (HVAC) systems etc.. One can also envisage further improvements in terms of 
response time by accelerating bacterial attachment by using antibodies or carbohydrate 
coatings such as mannose. Undoubtedly, in a real biological or industrial system, the 
environment is far more complicated and polymicrobial biofilms tend to dominate. Although 
the polymicrobial nature of biofilms would not limit the performance of our sensor, 
additional sample or surface treatments may be used with our sensing system in order to 
improve specificity. For instance, pre-filtering or surface functionalisation could be employed 
in biofilm related bloodstream infection studies in order to gain some insight on the roles of 
each species in a biofilm community. Reports have also shown that the growth dynamics of a 
polymicrobial biofilm involve some extra phases (42), which can be further explored using 
our sensor system in future work. 
 
Overall, we believe that our technique may be widely applicable both in industry and 
healthcare for fundamental studies and for applications that require the detection and 
monitoring of biofilms. With its high sensitivity to any changes in the substratum of biofilms, 
our sensor can be used in conjunction with other conventional techniques in order to gain a 
comprehensive understanding of biofilm formation, tolerance and antimicrobial resistance. 
Methods 
Bacterial strain and growth conditions 
E.coli K-12 carrying the F conjugative plasmid, also known as E.coli TG1, is chosen in this 
work as it has been shown previously to promote thick, mature biofilms within a short period 
of time (43,44). A single colony is inoculated into a test tube containing 25 ml of liquid 
Luria-Bertani (LB) broth and placed in an orbital rotating shaker at 100 rpm overnight at 
37°C. Some of this culture is then transferred and diluted within a fresh tube of LB broth to 
obtain the required concentrations of the microbial suspension. Optical density (OD) 
measurements are performed alongside separate cell counting on LB agar plates to determine 
bacterial concentrations. For example, OD600nm = 0.2 corresponds to a 2 x 108 CFU/ml 
concentration.  
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Fabrication of resonance gratings and flow cell 
In order to fabricate the gratings, a 150 nm Si3N4/glass substrate is cleaned in a piranha 
solution (hydrogen peroxide: sulfuric acid = 1:3 ratio), rinsed in acetone and isopropanol, and 
dried with nitrogen. The substrate is then coated with e-beam resist (ARP-13, AllResist 
GmbH), spun at 5000 rpm for 60 s, and baked at 180°C for 10 min, resulting in a film of 
approximately 400 nm. For charge dissipation during e-beam exposure, a thin film of 
aluminium (20 nm) is deposited on top of the resist using a thermal evaporator (HEX, 
Mantis). The grating pattern is defined in the e-beam resist using an electron beam 
lithography system (Raith GmbH Voyager 50 kV), followed by pattern transfer into the 
substrate using reactive ion etching with a gas mixture of CHF3 and O2. The depth of the 
grating in the substrate is 150 nm. The aluminium layer is removed in phosphoric acid and 
the residue of e-beam resist is removed with Microposit resist remover 1165 (MicroChem). 
The fabricated grating is then fixed to the bottom of a sterile quartz glass container. The flow 
of E.coli culture is generated by a peristaltic pump with sterile silicone tubes from a reservoir 
of culture, typically a total of 40 ml, in a 37°C water bath. Each set of experiments (including 
each E.coli concentration, references, each antibiotic and different concentrations) were 
repeated a minimum of 3 independent times. 
 
Live/dead staining and confocal microscopy 
After a certain time of growth, the grating is taken out from the flow cell, gently washed with 
phosphate buffered saline (PBS) buffer (Sigma-Aldrich) three times to remove the remains of 
the medium and planktonic cells, as well as loosely attached non-biofilm cells, and then 
incubated for 15 min in the dark with the BacLight Live/Dead viability kit (Thermo Fisher 
Scientific) to stain the cells with two fluorescent dyes, SYTO® 9 (green) and propidium 
iodide (red). Samples were then rinsed twice with PBS buffer and sealed under a coverslip. 
The stained biofilms on the grating are visualised using a ZEISS LSM 880 Confocal 
Microscope with a plan apochromat 63x/1.4 oil-immersion objective. The Live/Dead viability 
kit stains live cells green, dead cells red and some cells appear yellow or orange indicating 
that those bacteria are injured with possibly compromised cell membranes (45). 
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Antibiotic preparation and MIC assay 
Stock solution of 10 mg/ml of four antibiotics, i.e. trimethoprim, nitrofurantoin, rifampicin 
and ciprofloxacin (Sigma-Aldrich), are prepared by dissolving in DMSO, diluting in 
deionized water and filter sterilizing (0.22 µm syringe filter, Fisher Scientific). A 
microdilution assay was also performed on 96-well plates by exposing E. coli TG1 to a serial 
dilution of trimethoprim, nitrofurantoin, rifampicin and ciprofloxacin, in order to determine 
the MIC of each drug. The reporter dye resazurin was added to indicate the viability status of 
the cells (46). For more details on the protocol, see SI. The MIC measurements were 
performed with OD = 0.2, i.e. 2x108 cfu/ml, and repeated for four times. 
Bacteria spiked urine sample 
For the bacteria spiked urine sample shown in Fig. S8, an overnight-grown suspension of 
E.coli cells in LB broth is centrifuged at 8000 rpm for 10 min, and washed in syringe-filtered 
human urine (0.22 µm filter, Fisher Scientific). This process is repeated three times. Then the 
E.coli cells are resuspended in syringe-filtered human urine and the final concentration is 
made to be 2 x 108 CFU/ml in urine. 
 
Data and code availability 
The authors declare that all the data and MATLAB code supporting the findings of this study 
are available within the article and its supplementary information, or upon request from the 
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Supplementary information 
 
I. Hyperspectral image vs. confocal microscope image 
 
 
Fig S1. (a) Hyperspectral image at 5h from the start of the experiment with initial e.coli 
concentration of 2x108 cfu/ml; (b) a corresponding confocal microscope image of the 
same biofilm. 
 
II. Uncertainty in resonance wavelength 
 
The uncertainty in resonance wavelength, λn, is determined by monitoring the grating’s 
resonance with a constant water flow. Over 7.5	h, the standard deviation (σ) of the resonance 
wavelength is measured to be 0.037 nm. And we estimate the smallest detectable shift to be 
3σ, which is 0.111 nm. The resonance wavelength shift, which is defined as ᐃλ = λn – λ0, has 
a standard deviation σ of 0.055 nm and 3σ of 0.157 nm. 
III. Baclight Live/Dead viability assays  
Samples are prepared in the flow cell for various lengths of time, i.e. 1 h, 3.5 h, 5 h and 10 h, 
with initial E.coli TG1 concentration of 2 x 108 CFU/ml. The gratings are then taken out from 
the flow cell, gently washed three times with phosphate buffered saline (PBS) buffer three 
times and stained with the Baclight Live/Dead viability assay. The washing steps are essential 
for removing loosely attached non-biofilm cells. The samples are then incubated at room 
temperature in the dark for 15 minutes. Fluorescent images are then taken with a ZEISS LSM 
880 single-photon confocal microscope. It is worth noting here that for the short-time-grown 
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sample (1 h in the flow cell), some bacteria were washed away from the grating surface 
during the staining process, due to weak attachment to the surface during this stage - this 
image therefore does not reflect the true nature of the sample in this case.  
 
    
Fig S2. Confocal microscopic images of early-stage biofilms on the sensor surface. 1 h, 
3.5 h, 5 h and 10 h biofilm samples are stained with the Live/Dead BacLight viability assay 
and examined with a ZEISS LSM 800 confocal microscope. The scale bars in the 
micrographs are all 10 μm long. 
 
IV. Biofilm formation time  
The relationship between the bacterial seeding density and the “planktonic” phase time tplank 
is plotted in Fig. S3. Although it is intuitive that a lower initial inoculum density leads to a 
longer biofilm formation time, the technique readily allows us to quantify this formation 
time.  
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Fig S3. Estimation of initial bacterial numbers.  Relationship between the initial bacterial 
concentration and the “planktonic” phase time duration of the early-stage biofilm (tplank in 
Eq.1) in a log-linear plot. The solid line is a linear fit to the data points. The error bars 
represent the standard deviations of repeated experiments. 
 
 
V. Determining the MICs 
 
We use a resazurin-based microdilution assay to determine the minimum inhibitory 
concentrations (MICs) of different drugs. Trimethoprim, nitrofurantoin, rifampicin and 
ciprofloxacin are diluted from individual stock solutions to 1024 μg/ml. In a 96-well plate, 
column 1 of is used as a no antibiotic control and column 12 contains only LB broth as a 
sterility control (see Fig. S4). For the antibiotic serial dilution, 50 μl of the 1024 μg/ml 
antibiotic solution is first added to the 512 μg/ml column, and is well mixed with the liquid 
culture using a multichannel pipette before transferring to the next well, and repeated twice, 
to give a range of concentrations between 1 to 512 μg/ml, see Fig. S4. 
 
E. coli TG1 are grown overnight in LB at 37ºC and shaken at 200 rpm. Cells are washed three 
times in Mueller Hinton broth (MH) then re-suspended in MH before first being diluted to 0.1 
OD to give standardised suspension of 108 cfu/ml. The standardised suspension is diluted 1:100 
then 50 μl added to each well to give a final bacteria concentration of 5.5x105 cfu/ml. 50 μl 
MHB is added to column 12 to give 100 μl of solution in all wells. After overnight incubation 
at 37°C, 30 μl of 0.015% solution of resazurin in MHB is introduced in each well and incubated 
for 4 hours. Results are validated by visual inspection of the wells. 
 
The MIC microdilution experiments have been repeated for four times (twice with resazurin 
dye, twice without dye but the growth curves were monitored). The MICs of each drug are 0-
1 μg/ml (trimethoprim), 4-8 μg/ml (nitrofurantoin), 8-16 μg/ml (rifampicin) and 0-1 μg/ml 
(ciprofloxacin). The MIC measurements were all performed with OD = 0.2, i.e.2 x 108 cfu/ml 
diluted from overnight cultures. 
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Fig. S4. A resazurin microdilution assay with four different antibiotics. The concentration 
of the four antibiotics, nitrofurantoin, ciprofloxacin, trimethoprim and rifampicin, is increased 
along the columns from 0 to 512 μg/ml. Each antibiotic has been tested in duplicate. The first 
column has no antibiotic and the last column has only LB broth with no bacteria. Pink colour 
indicates growth and dark purple means inhibition of growth. 
 
VI. Antibiotics susceptibility test 
 
 
Fig. S5. Trimethoprim susceptibility testing in established biofilms. Trimethoprim at 
doses ranging from 10x to 500x MIC is introduced into the culture at 5 h (as indicated by the 
vertical dashed line). We observe no change within experimental accuracy, which suggests 
that trimethoprim has no effect on the biofilm. 
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Fig. S6. Nitrofurantoin susceptibility testing in established biofilm. Nitrofurantoin with a 
concentration of 500x MIC is introduced into the culture at 5 h, and we observe no change in 
resonance wavelengths in the following 15 hours. 
 
     
Fig. S7. Confocal microscopic images of biofilms on the grating surface after 10 h from 
the start of the experiments. With no antibiotic injected as a reference (left), with 150x MIC 
(middle), 500x MIC (right) of trimethoprim injected at 5 h from the start of the experiment. 
The biofilms were stained with the LIVE/DEAD BacLight viability stain assay at 10 h and 
cells with compromised membranes stain red, whereas cells with intact membranes stain 
green. The scale bars in the images are 10 μm. 
VII. Biofilm formation in bacteria spiked urine 
Finally, we verify our technique’s capability of working with a more complicated and 
biological growth culture, i.e. urine. A starting culture of E.coli TG1 was made from an 
overnight culture in LB broth. 50 ml cell suspension was spun down and washed three times 
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in human urine (prefiltered using 0.2 μm pore size membrane filters). A suspension with 
E.coli inoculum density of 2 x 108 CFU/ml, was flown through the sensor with the resonance 
wavelength shift monitored, see Fig. S8. Interestingly, the sensor detected full biofilm 
coverage within 60 minutes, i.e. significantly faster than in LB. This demonstrates that our 
sensor is capable of operating with a relevant biological matrix. 
 
 
Fig. S8. Biofilm detection in bacterial spiked human urine. Biofilm growth is detected by 
the sensor in the flow cell with a suspension with E.coli inoculum concentration of 2 x 108 
CFU/ml in human urine. 
 
 
